Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2008 2
2009 2
2010 2
2011 4
2012 3
2013 7
2014 9
2015 3
2016 3
2017 2
2018 5
2019 7
2020 7
2021 7
2022 9
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for shugan zhang
Search for Shugen Zhang instead (1 results)
Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3beta/PTEN/Akt pathway.
Fan Q, Liu Y, Sheng L, Lv S, Yang L, Zhang Z, Guo J, Fan Y, Hu D. Fan Q, et al. Biomed Pharmacother. 2023 Apr;160:114385. doi: 10.1016/j.biopha.2023.114385. Epub 2023 Feb 10. Biomed Pharmacother. 2023. PMID: 36774722 Free article.
The rats were then allocated to experimental groups (n = 15) that were treated with Chaihu-Shugan-San, a JAK-STAT3 inhibitor, a GSK3beta overexpressing virus, or an empty virus (control). ...Flow cytometry showed microglia polarization towards the M1 phenotype in an in vit …
The rats were then allocated to experimental groups (n = 15) that were treated with Chaihu-Shugan-San, a JAK-STAT3 inhibitor, a GSK3b …
Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems.
Zhang M, Bai X. Zhang M, et al. Front Pharmacol. 2022 Jan 24;13:821270. doi: 10.3389/fphar.2022.821270. eCollection 2022. Front Pharmacol. 2022. PMID: 35140618 Free PMC article. Review.
TCM has a very long history of being used to treat depression, and various TCM prescriptions have been clinically proven to be effective in improving depression. Among the numerous prescriptions for treating depression, Shugan Jieyu capsule (SG) is one of the classic presc …
TCM has a very long history of being used to treat depression, and various TCM prescriptions have been clinically proven to be effective in …
Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress.
Zhu X, Li T, Hu E, Duan L, Zhang C, Wang Y, Tang T, Yang Z, Fan R. Zhu X, et al. Front Pharmacol. 2022 Jan 17;12:791097. doi: 10.3389/fphar.2021.791097. eCollection 2021. Front Pharmacol. 2022. PMID: 35111057 Free PMC article.
Compared with Shu Gan and Rou Gan, the 22 Chaihu-Shugan-San advanced proteins and the affected GABA pathway may be the advantages of Chaihu-Shugan-San compatibility. This research offers data and theory support for the clinical application of Chaihu-Shugan-Sa …
Compared with Shu Gan and Rou Gan, the 22 Chaihu-Shugan-San advanced proteins and the affected GABA pathway may be the advantages of …
Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer.
Fan T, Huang Y, Liu Z, Huang J, Ke B, Rong Y, Qiu H, Zhang B. Fan T, et al. Drug Des Devel Ther. 2024 Apr 10;18:1115-1131. doi: 10.2147/DDDT.S394287. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38618280 Free PMC article.
BACKGROUND: The ChaiShao Shugan Formula (CSSGF) is a traditional Chinese medicine formula with recently identified therapeutic value in triple-negative breast cancer (TNBC). ...
BACKGROUND: The ChaiShao Shugan Formula (CSSGF) is a traditional Chinese medicine formula with recently identified therapeutic value …
Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
Zheng C, Nie H, Pan M, Fan W, Pi D, Liang Z, Liu D, Wang F, Yang Q, Zhang Y. Zheng C, et al. J Ethnopharmacol. 2024 Jan 10;318(Pt A):116967. doi: 10.1016/j.jep.2023.116967. Epub 2023 Jul 26. J Ethnopharmacol. 2024. PMID: 37506783
ETHNOPHARMACOLOGICAL RELEVANCE: Chaihu Shugan powder (CSP) plays an important role in the prevention and treatment of nonalcoholic fatty liver disease (NAFLD) through a variety of biological mechanisms. ...
ETHNOPHARMACOLOGICAL RELEVANCE: Chaihu Shugan powder (CSP) plays an important role in the prevention and treatment of nonalcoholic fa …
An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
Wang S, Chen B, Du R, Zhong M, Zhang C, Jin X, Cui X, Zhou Y, Kang Q, Xu H, Li Y, Wu Q, Tong G, Luo L. Wang S, et al. J Ethnopharmacol. 2024 Jul 15;329:118127. doi: 10.1016/j.jep.2024.118127. Epub 2024 Apr 5. J Ethnopharmacol. 2024. PMID: 38583728 Free article.
ETHNOPHARMACOLOGICAL RELEVANCE: Shugan Xiaozhi (SGXZ) decoction is a traditional Chinese medicine used for treating nonalcoholic steatohepatitis (NASH). ...
ETHNOPHARMACOLOGICAL RELEVANCE: Shugan Xiaozhi (SGXZ) decoction is a traditional Chinese medicine used for treating nonalcoholic stea …
Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation.
Lei S, Zhao S, Huang X, Feng Y, Li Z, Chen L, Huang P, Guan H, Zhang H, Wu Q, Chen B. Lei S, et al. Front Pharmacol. 2022 Sep 12;13:967623. doi: 10.3389/fphar.2022.967623. eCollection 2022. Front Pharmacol. 2022. PMID: 36172180 Free PMC article.
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic disease and is intertwined with cardiovascular disorders and diabetes. Chaihu Shugan powder (CSP) is a traditional Chinese medicine with a significant therapeutic effect on metabolic diseases …
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic disease and is intertwined with cardiovascular disorders a …
Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M(3) Receptor Expression.
Wang Y, Dong Y, Wang E, Meng Y, Bi Z, Sun S, Zhang C, Fan H, Yuan J. Wang Y, et al. Front Pharmacol. 2020 Sep 11;11:01082. doi: 10.3389/fphar.2020.01082. eCollection 2020. Front Pharmacol. 2020. PMID: 33013355 Free PMC article.
AIM: We investigated whether gut motor function was altered in SERT-knockout (SERT-KO) rats. Additionally, we sought to determine whether Shugan decoction (SGD), a clinically experienced prescription for the treatment of IBS, exerts regulatory effects on intestinal motilit …
AIM: We investigated whether gut motor function was altered in SERT-knockout (SERT-KO) rats. Additionally, we sought to determine whether …
Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi Capsule for treating non-alcoholic fatty liver disease.
Zhu T, Huang X, Zhu H, Chen J, Yao H, Zhang Y, Hua H, Zhang J, Qi J. Zhu T, et al. Phytomedicine. 2024 Jan;123:155173. doi: 10.1016/j.phymed.2023.155173. Epub 2023 Oct 29. Phytomedicine. 2024. PMID: 37976695
BACKGROUND: ShuGan-QieZhi capsule (SGQZC) is a traditional Chinese preparation used to treat hyperlipidemia and obesity, even non-alcoholic fatty liver disease (NAFLD). ...
BACKGROUND: ShuGan-QieZhi capsule (SGQZC) is a traditional Chinese preparation used to treat hyperlipidemia and obesity, even non-alc …
Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
Liu N, Li J, Wang Y, Zhang S. Liu N, et al. J Ethnopharmacol. 2023 Dec 5;317:116672. doi: 10.1016/j.jep.2023.116672. Epub 2023 Jun 14. J Ethnopharmacol. 2023. PMID: 37328079 Review.
ETHNOPHARMACOLOGICAL RELEVANCE: Shuganjianpi Therapy (SGJP), Jianpi Therapy (JP), Shugan Therapy (SG), Jianpiwenshen Therapy (JPWS), and Shuganjianpiwenshen Therapy (SGJPWS), consisting of formulas from Chinese herbal medicine (CHM), have been tremendously applied to irrit …
ETHNOPHARMACOLOGICAL RELEVANCE: Shuganjianpi Therapy (SGJP), Jianpi Therapy (JP), Shugan Therapy (SG), Jianpiwenshen Therapy (JPWS), …
87 results